NCT01023893View on ClinicalTrials.gov

Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1)

UnknownOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2010

Conditions
Renal Replacement Therapy
Sponsors

Lead Sponsor

ProMetrics, Inc.
All Listed Sponsors
lead

ProMetrics, Inc.

INDUSTRY

NCT01023893 - Blood Viscosity, End-Stage Renal Disease, And Mortality (BEAM-1) | Biotech Hunter | Biotech Hunter